Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 4/20 | 0.50 |
| ▸ | AHCY | P23526 | 1/20 | 0.45 |
| ▸ | ADA | P00813 | 1/20 | 0.44 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.44 |
| ▸ | HINT1 | P49773 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.41 |
| ▸ | NT5E | P21589 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19859703 | 0.90 | ADORA2A (0.46) | ADORA2AAHCYADAHSP90B1HINT1 | |
| SCHEMBL19859805 | 0.86 | ADORA2A (0.62) | ADORA2AAHCYADORA3 | |
| SCHEMBL21078466 | 0.85 | AHCY (0.43) | ADORA2AAHCYADAHSP90B1ADORA3 | |
| SCHEMBL15833022 | 0.82 | ADORA3 (0.52) | ADORA2AHINT1ADORA3NT5E | |
| SCHEMBL15833215 | 0.82 | ADORA3 (0.52) | ADORA2AHINT1ADORA3NT5E | |
| SCHEMBL15837259 | 0.79 | ADORA3 (0.39) | ADORA2AADAHINT1ADORA3 | |
| SCHEMBL21078497 | 0.79 | ADORA3 (0.49) | ADORA2AADORA3LMNA | |
| SCHEMBL31228203 | 0.78 | ADORA2A (0.39) | ADORA2AAHCYADAHSP90B1HINT1 | |
| SCHEMBL19778486 | 0.78 | HTR2C (0.41) | ADORA2AAHCYADAHSP90B1ADORA3 | |
| SCHEMBL21015191 | 0.78 | ADORA3 (0.53) | ADORA2AAHCYADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |